NOVIOGENDIX HOLDING
NovioGendix, a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer. NovioGendix, based in Nijmegen (The Netherlands), is a molecular diagnostic company providing an expert-based, integrated approach in developing advanced and clinically useful molecular diagnostic assays for uro-oncological practice. NovioGendix has a range of diagnostic tests for prostate, bladder, kidney and other urologic cancers in various stag... es of development. Commencing activities in 2008 as a Radboud University Medical Center (Radboudumc) spin-off company, NovioGendix has a standing cooperation with various Radboudumc departments. The main shareholders of NovioGendix include BioGeneration Ventures, and Participatiemaatschappij Oost Nederland.
NOVIOGENDIX HOLDING
Industry:
Health Care
Founded:
2006-01-01
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.noviogendix.nl
Total Employee:
1+
Status:
Closed
Contact:
866.259.5644
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
Official Site Inspections
http://www.noviogendix.nl
- Host name: 23.227.38.67
- IP address: 23.227.38.67
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Noviogendix Holding"
Noviogendix Holding - Crunchbase Company Profile & Funding
NovioGendix, a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer. NovioGendix, based in Nijmegen (The …See details»
Novigenix - the leading Immuno-Transcriptomics company
The leading Immuno-Transcriptomics company: Generating insights from tumor-host interaction in order to detect cancer as early as possible and tailor the right treatment for the right patient.See details»
NovioGendix Holding B.V. - life-sciences-europe.com
NovioGendix, based in Nijmegen (The Netherlands), is a molecular diagnostic company providing an expert-based, integrated approach in developing advanced and clinically useful molecular …See details»
NovioGendix 2025 Company Profile: Valuation, Investors
Information on acquisition, funding, cap tables, investors, and executives for NovioGendix. Use the PitchBook Platform to explore the full profile.See details»
NovioGendix Holding BV - Ownership and Business Overview
NovioGendix Holding BV is a molecular diagnostic research and service company providing an expert-based, integrated approach in developing advanced and clinically useful molecular …See details»
MDxHealth Acquires NovioGendix to Expand Uro-Oncology …
The NovioGendix facility in the Netherlands allows us to expand our presence in Europe and will serve as a platform to launch the SelectMDx TM IVD kit on the European market in 2016.” …See details»
NovioGendix - BioGeneration Ventures
In 2010 MDxHealth acquired NovioGendix.NovioGendix is developing a new biomarker panel for the detection and management of prostate cancer and other cancers.See details»
NovioGendix - VentureRadar
"NovioGendix offers molecular diagnostics services through its accreditated laboratory, and performs research in the field of the discovery of new diagnostic markers for cancer.See details»
Noviogendix Holding BV Company Profile, Financial and
This report contains Noviogendix Holding BV company and market share data which will help you understand the detailed picture of company’s financial position. In-depth analysis performed to …See details»
NovioGendix Holding BV - Company Profile and News
Company profile page for NovioGendix Holding BV including stock price, company news, executives, board members, and contact informationSee details»
NovioGendix Research B.V. Nijmegen - Oozo.nl
De besloten vennootschap NovioGendix Research B.V. is gevestigd op Geert Grooteplein Zuid 34 te Nijmegen en is actief in de branche Natuurwetenschappelijk speur- en ontwikkelingswerk …See details»
Dutch company acquired by MDxHealth - BioVox
Sep 21, 2015 The Dutch biotech company NovioGendix is acquired by the Belgian company MDxHealth. MDxHealth will pay $ 8.8 million (€ 7.8 million) for the Nijmegen-based company. …See details»
NovioGendix - Company Profile - Tracxn
NovioGendix develops urine-based cancer diagnostic tests. Its flagship product was a mRNA-based biomarker urine test that identifies men with a low risk of developing prostate cancer.See details»
NovioGendix - Company Profile & Staff Directory | ContactOut
NovioGendix is a Biotechnology company with 20 employees. Access NovioGendix's email format and NovioGendix staff directory for direct contact details of 20 employees.See details»
NovioGendix - dealmaker.nl
NovioGendix, based in Nijmegen (The Netherlands), is a molecular diagnostic company providing an expert-based, integrated approach in developing advanced and clinically useful molecular …See details»
NovioGendix - Products, Competitors, Financials, Employees ...
NovioGendix is a privately-held molecular diagnostics company focused on the development of a non-invasive liquid biopsy test for prostate cancer. Use the CB Insights Platform to explore …See details»
Noviogendix Holding company information, funding & investors
Noviogendix Holding, provider of molecular diagnostics and services to physicians, clinics, and hospitals to personalize the diagnosis and treatment of cancer. Here you'll find information …See details»
Mdxhealth Servicelab BV 09164803 - datocapital.nl
Reports, financial statements, director data and filing documents of Mdxhealth Servicelab BV, in geert Grooteplein Zuid 34 Nijmegen, Netherlands...See details»
NovioGendix Holding BV - Drug pipelines, Patents, Clinical trials
Explore NovioGendix Holding BV with its drug pipeline, therapeutic area, technology platform, .See details»
NovioGendix Holding B.V - Medical Equipment - Deals and …
NovioGendix is headquartered in Nijmegen, the Netherlands. NovioGendix Holding B.V - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis …See details»